3D Medical Expo welcomes Poietis as Start-Up Partner
Poietis is a company specialized in the development and manufacturing of human tissues using 4D bioprinting.
Poietis markets Poieskin®, first commercial bioprinted human tissue, and developed the multimodal bioprinting platform NGB («Next Generation Bioprinting»), which includes the commercially available NGB-R bioprinter, for R&D, and the NGB-C system for clinical applications. Continue reading “3D Medical Expo welcomes Poietis as Start-Up Partner”
Announcement by Servier and Poietis of scientific partnership in 4D bioprinting of liver tissues
Paris and Pessac, France – 19 September 2018 – Servier, an independent international pharmaceutical company, and Poietis, a leader in the production of living bioprinted tissues, have announced a scientific partnership to use Poietis’s 4D bioprinting technology for the development and production of liver tissues.
This partnership seeks to improve the detection of drug-induced liver lesions as early as the preclinical trial phase. Such lesions are rare1 but can have serious consequences for patients. This hepatotoxic2 potential is poorly detected by current preclinical models. Beyond animal models, various models based on human cell cultures are available, but most lack longevity and complexity, which limits their usefulness in toxicology. Poietis’s 4D bioprinting technology has emerged as an innovative technology capable of helping to overcome these limitations. Continue reading “Announcement by Servier and Poietis of scientific partnership in 4D bioprinting of liver tissues”
Toward bioprinting industrialization – Presented by Fabien Guillemot, Poietis at the 3D Medical Conference, which will take place on 30-31 January 2018 at MECC Maastricht, The Netherlands.
Bioprinting has been defined as “the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies”.
From a technological point of view, different bioprinting technologies have been developed so far. Recently, Laser-Assisted Bioprinting (LAB) technology has emerged as an alternative method to inkjet and bioextrusion methods, thereby overcoming some of their limitations (namely clogging of print heads or capillaries) to pattern living cells and biomaterials with a micron-scale resolution and high cell viability. Continue reading “Toward bioprinting industrialization – Presented by Fabien Guillemot, Poietis”
Partnership for bio-printing of hair, signed by Poietis and L’Oreal. L’Oreal has been committed to tissue engineering for almost 30 years and holds unique knowledge and expertise in the field of bio-printing of hair. With this exclusive research partnership, L’Oreal and Poietis are giving themselves the means to pursue a new scientific challenge: bio-printing a hair follicle, the small organ that produces hair, using a bio-printer. Continue reading “Partnership for bio-printing of hair, signed by Poietis and L’Oreal”
Poietis, French leader of Bioprinting, continues its growth by closing a first round of financing of €2.5 million including a fundraising record of nearly €1 million via the crowdfunding platform WiSEED. The funds raised will be used to industrialize Poietis Laser-Assisted Bioprinting technology and bring to market its first bioprinted tissues. Continue reading “French Poietis raises €2.5mn financing to develop technology that will bring to market its first bioprinted tissues”
A French start-up has developed unique technology for 4D laser bioprinting of living tissue. This is a promising system for a tissue engineering market worth an estimated 15 billion dollars.
Poietis has pulled off an extraordinary gamble: to design living tissue – cell layer by cell layer – just like printed objects. It has achieved this via a 3D laser printer, which uses cells and biomaterial instead of paper and ink. Continue reading “French Start-up Develops Unique Technology for 4D Laser Bioprinting of Living Tissue”